Back to STATE STREET CORP STATE STREET CORP

DNLIDNLI
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in DENALI THERAPEUTICS INC

STATE STREET CORP holds 7M shares of DNLI (DENALI THERAPEUTICS INC), worth $181.3M as of 2026-Q2. The position was increased (+12.4% shares). DNLI represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$181.3M

Current Shares

7M

Total Value Change

+$63.6M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7M
+12.4%
$181.3M0.0%$25.72
34
2026-Q1
Increased
6.3M
+0.1%
$120.4M0.0%$20.02
30
2025-Q4
Increased
6.3M
+14.6%
$103.4M0.0%$16.41
34
2025-Q3
Increased
5.5M
+20.9%
$79.3M0.0%$14.52
36
2025-Q2
Increased
4.5M
+1.3%
$63.2M0.0%$14.10
30
2025-Q1
Decreased
4.5M
-1.9%
$60.6M0.0%$14.78
0
2024-Q4
Increased
4.5M
+6.9%
$92.6M0.0%$20.24
32
2024-Q3
Decreased
4.3M
-4.1%
$123.9M0.0%$29.43
0
2024-Q2
Decreased
4.4M
-29.9%
$103M0.0%$23.22
0
2024-Q1
Increased
6.3M
+15.3%
$129.8M0.0%$20.52
35
2023-Q4
New
5.5M
-
$117.7M0.0%$21.46
42

Other major holders of DNLI: BAILLIE GIFFORD & CO, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used